Realm Therapeutics, Inc. (Biotechnology, Pharmaceutical) — Funding, Investors & Signals 2026

Realm Therapeutics, Inc.

Founded 2006

Malvern, United States 2 employees Post Ipo Equity Total: $26.00M Biotechnology, Pharmaceutical

Realm Therapeutics is a clinical-stage biopharmaceutical company (AIM: RLM) focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes its formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas, including Dermatology and Ophthalmology. Realm Therapeutics, founded in 2006 and headquartered in the United States, is advancing its immunomodulatory technology against inflammatory diseases with high unmet needs in Dermatology and Ophthalmology. The company has developed proprietary formulations of its novel technology for initial application in Atopic Dermatitis (PR022), Acne (PR023), and Allergic Conjunctivitis (PR013), as reflected in its pipeline chart at www.realmtx.com. The latest investment in Realm Therapeutics amounted to $26.00M in post-IPO equity, received on 22 September 2017. This investment came from notable venture capital firms including RA Capital Management, Abingworth, OrbiMed, BVF Partners, and Polar Capital. With its innovative technology and focus on unmet medical needs in Dermatology and Ophthalmology, Realm Therapeutics presents an appealing opportunity for investors looking to support groundbreaking developments in the biotechnology and pharmaceutical industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Post-IPO Equity	••••••	5	•••• ••••	22 Sep 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Post-IPO Equity

••••••

•••• ••••

22 Sep 2017

FAQ About Realm Therapeutics, Inc.

Realm Therapeutics (AIM: RLM) is a clinical-stage biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at...

Realm Therapeutics, Inc. was founded in 2006.

Realm Therapeutics, Inc. is headquartered in Malvern, United States.

Realm Therapeutics, Inc. operates in the following industries: Biotechnology, Pharmaceutical.

Realm Therapeutics, Inc. has approximately 2 employees.

Realm Therapeutics, Inc. has completed 1 funding round, raising a total of $26.00M. The latest funding stage is Post Ipo Equity.

Top alternatives and competitors to Realm Therapeutics, Inc. include PuriCore, Aegle Therapeutics, Trefoil Therapeutics, PYC Therapeutics (ASX: PYC), ASC Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Realm Therapeutics, Inc. and PuriCore are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Realm Therapeutics, Inc.

General Information

Track Realm Therapeutics, Inc.

Discover More

About Realm Therapeutics, Inc.

Funding Rounds & Investors (1)

Realm Therapeutics, Inc. Alternatives & Competitors

FAQ About Realm Therapeutics, Inc.

Don't just browse. Track.